1. Lin, Meng, Zhao, Zhiyao, Yang, Zhifen, Wang, Rong-Fu, Cui, Jun. 2016. USP38 Inhibits Type I Interferon Signaling by Editing TBK1 Ubiquitination through NLRP4 Signalosome. In Molecular cell, 64, 267-281. doi:10.1016/j.molcel.2016.08.029. https://pubmed.ncbi.nlm.nih.gov/27692986/
2. Wang, Rui, Cai, Xiaolian, Li, Xiong, Wang, Jing, Xiao, Wuhan. 2023. USP38 promotes deubiquitination of K11-linked polyubiquitination of HIF1α at Lys769 to enhance hypoxia signaling. In The Journal of biological chemistry, 300, 105532. doi:10.1016/j.jbc.2023.105532. https://pubmed.ncbi.nlm.nih.gov/38072059/
3. Manjurano, Alphaxard, Sepúlveda, Nuno, Nadjm, Behzad, Riley, Eleanor M, Clark, Taane G. 2015. USP38, FREM3, SDC1, DDC, and LOC727982 Gene Polymorphisms and Differential Susceptibility to Severe Malaria in Tanzania. In The Journal of infectious diseases, 212, 1129-39. doi:10.1093/infdis/jiv192. https://pubmed.ncbi.nlm.nih.gov/25805752/
4. Xu, Zhijun, Hu, Hao, Fang, Debao, Wang, Jiong, Zhao, Kailiang. 2021. The deubiquitinase USP38 promotes cell proliferation through stabilizing c-Myc. In The international journal of biochemistry & cell biology, 137, 106023. doi:10.1016/j.biocel.2021.106023. https://pubmed.ncbi.nlm.nih.gov/34102342/
5. Wang, Zhiru, Kang, Wenting, Li, Ouwen, Zheng, Yichao, Liu, Hong-Min. 2020. Abrogation of USP7 is an alternative strategy to downregulate PD-L1 and sensitize gastric cancer cells to T cells killing. In Acta pharmaceutica Sinica. B, 11, 694-707. doi:10.1016/j.apsb.2020.11.005. https://pubmed.ncbi.nlm.nih.gov/33777676/
6. Zhao, Zhiyao, Su, Zexiong, Liang, Puping, Huang, Junjiu, Cui, Jun. 2020. USP38 Couples Histone Ubiquitination and Methylation via KDM5B to Resolve Inflammation. In Advanced science (Weinheim, Baden-Wurttemberg, Germany), 7, 2002680. doi:10.1002/advs.202002680. https://pubmed.ncbi.nlm.nih.gov/33240782/
7. Wang, Jun, Gu, Yongxing, Yan, Xueqin, Wang, Jun, Ding, Yong. 2022. USP38 inhibits colorectal cancer cell proliferation and migration via downregulating HMX3 ubiquitylation. In Cell cycle (Georgetown, Tex.), 22, 1169-1181. doi:10.1080/15384101.2022.2042776. https://pubmed.ncbi.nlm.nih.gov/36204976/
8. Hu, Qingyong, Chen, Yahui, Zhou, Qianru, Li, Chenghua, Tang, Jiancai. 2024. ADAR promotes USP38 auto-deubiquitylation and stabilization in an RNA editing-independent manner in esophageal squamous cell carcinoma. In The Journal of biological chemistry, 300, 107789. doi:10.1016/j.jbc.2024.107789. https://pubmed.ncbi.nlm.nih.gov/39303916/
9. Hu, Ting, Wang, Ke-Ni, LingHu, Hai-Rui. . USP38 might be a new therapeutic target for glioma via regulation of cancer cell metastasis. In Folia neuropathologica, 59, 359-371. doi:10.5114/fn.2021.112571. https://pubmed.ncbi.nlm.nih.gov/35114776/